Switch theme
Sign up to access all valuation multiples
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
1973
18.7K+
Last FY Revenue $1.8B
Last FY EBITDA $137M
$659M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Rhoen Klinikum achieved revenue of $1.8B and an EBITDA of $137M.
Rhoen Klinikum expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Rhoen Klinikum valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.8B | XXX | XXX | XXX |
| Gross Profit | XXX | $193M | XXX | XXX | XXX |
| Gross Margin | XXX | 11% | XXX | XXX | XXX |
| EBITDA | XXX | $137M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 8% | XXX | XXX | XXX |
| EBIT | XXX | $43.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | 2% | XXX | XXX | XXX |
| Net Profit | XXX | $48.7M | XXX | XXX | XXX |
| Net Margin | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Rhoen Klinikum's stock price is EUR 13 (or $14).
Rhoen Klinikum has current market cap of EUR 864M (or $970M), and EV of EUR 586M (or $659M).
See Rhoen Klinikum trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $659M | $970M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Rhoen Klinikum has market cap of $970M and EV of $659M.
Rhoen Klinikum's trades at 0.4x EV/Revenue multiple, and 4.8x EV/EBITDA.
Equity research analysts estimate Rhoen Klinikum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Rhoen Klinikum's P/E ratio is not available.
See valuation multiples for Rhoen Klinikum and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $970M | XXX | $970M | XXX | XXX | XXX |
| EV (current) | $659M | XXX | $659M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 4.8x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 15.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 19.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 10.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialRhoen Klinikum's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $8K for the same period.
Rhoen Klinikum's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Rhoen Klinikum's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Rhoen Klinikum and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $8K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Rhoen Klinikum acquired XXX companies to date.
Last acquisition by Rhoen Klinikum was XXXXXXXX, XXXXX XXXXX XXXXXX . Rhoen Klinikum acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Rhoen Klinikum founded? | Rhoen Klinikum was founded in 1973. |
| Where is Rhoen Klinikum headquartered? | Rhoen Klinikum is headquartered in Germany. |
| How many employees does Rhoen Klinikum have? | As of today, Rhoen Klinikum has 18.7K+ employees. |
| Is Rhoen Klinikum publicy listed? | Yes, Rhoen Klinikum is a public company listed on ETR. |
| What is the stock symbol of Rhoen Klinikum? | Rhoen Klinikum trades under RHK ticker. |
| When did Rhoen Klinikum go public? | Rhoen Klinikum went public in 1989. |
| Who are competitors of Rhoen Klinikum? | Similar companies to Rhoen Klinikum include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Rhoen Klinikum? | Rhoen Klinikum's current market cap is $970M |
| Is Rhoen Klinikum profitable? | Yes, Rhoen Klinikum is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
